ECS Botanics Holdings Ltd is a public company specializing in the cultivation, manufacturing, and sale of medicinal cannabis products. Headquartered in Northwest Victoria, Australia, it operates within the pharmaceutical product manufacturing industry and leverages advanced, sustainable agricultural practices—including regenerative and organic horticulture and renewable energy usage—to produce high-quality cannabis-based medicines. The company's activities span both domestic and international markets, supporting healthcare providers and serving the growing medicinal cannabis sector. ECS Botanics Holdings Ltd holds licensing from the Australian Therapeutic Goods Administration to manufacture GMP-certified products, ensuring compliance with stringent quality standards. Its diversified operations, which include subsidiaries such as Flowerday Farms Pty Ltd, position ECS Botanics Holdings Ltd as an integral participant in the development and delivery of accessible medicinal cannabis solutions, reflecting broader trends in healthcare innovation and plant-based therapeutics. With a reported annual revenue exceeding AU$19 million in 2025, the company plays a significant role in supporting patients and practitioners seeking reliable pharmaceuticals while promoting sustainability within the industry.